Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study.

Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study.

<h4>Background</h4>Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown etiology. In several randomized clinical trials, and in the clinical practice, pirfenidone is used to effectively and safely treat IPF. However, sometimes it is di...

Full description

Bibliographic Details
Main Authors: Eung Gu Lee, Tae-Hee Lee, Yujin Hong, Jiwon Ryoo, Jung Won Heo, Bo Mi Gil, Hye Seon Kang, Soon Seog Kwon, Yong Hyun Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0261684

Internet

https://doi.org/10.1371/journal.pone.0261684

Similar Items